Emmanuelle di Tomaso

Phase II study of cediranib, an oral pan-vascular endothelial growth factor receptor tyrosine kinase inhibitor, in patients with recurrent glioblastoma.

Thomas Benner, Percy Ivy, Marek Ancukiewicz, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: role of oxygenation, angiopoietin-1, and matrix metalloproteinases.

Lei Xu, Dai Fukumura, M. F. Booth, 2004, Cancer cell.

In vivo validation of MRI vessel caliber index measurement methods with intravital optical microscopy in a U87 mouse brain tumor model.

A Gregory Sorensen, Guangping Dai, Y. R. Kim, 2010, Neuro-oncology.

Glioblastoma recurrence after cediranib therapy in patients: lack of "rebound" revascularization as mode of escape.

Tracy T Batchelor, A Gregory Sorensen, Matija Snuderl, 2011, Cancer research.

Efficacy, safety, and potential biomarkers of sunitinib monotherapy in advanced hepatocellular carcinoma: a phase II study.

Marek Ancukiewicz, Vivek Sindhwani, Onofrio A Catalano, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Lymphatic Metastasis in the Absence of Functional Intratumor Lymphatics

Rakesh K Jain, R. Jain, Y. Boucher, 2002, Science.

Imaging steps of lymphatic metastasis reveals that vascular endothelial growth factor-C increases metastasis by increasing delivery of cancer cells to lymph nodes: therapeutic implications.

Dai Fukumura, Tohru Hoshida, Rakesh K Jain, 2006, Cancer research.

PDGF-C Induces Maturation of Blood Vessels in a Model of Glioblastoma and Attenuates the Response to Anti-VEGF Treatment

Rakesh K. Jain, Lance L. Munn, Daniel Fuja, 2009, PloS one.

AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients.

Tracy T Batchelor, Thomas Benner, A Gregory Sorensen, 2007, Cancer cell.

Safety, Efficacy, and Biomarker Exploration in a Phase II Study of Bevacizumab, Oxaliplatin, and Gemcitabine in Recurrent Müllerian Carcinoma.

Marek Ancukiewicz, Rakesh K Jain, R. Jain, 2011, Clinical ovarian cancer and other gynecologic malignancies.

Mosaic tumor vessels: cellular basis and ultrastructure of focal regions lacking endothelial cell markers.

Rakesh K Jain, R. Jain, L. Munn, 2005, Cancer research.